Consultants

Dalit Barkan, Ph.D. - Cancer Recurrence Drug Discovery
Head, Laboratory of Tumor Dormancy and Metastasis, Department of Human Biology and Medical Sciences, Faculty of Natural Sciences, University of Haifa, Israel 


Gil Ben Menachem, Ph.D. - Business Development and Strategy  

Experienced biopharma executive. VP, BD at Kitov Pharma, formally Teva, Dexcel Pharma, Paramount Biosciences 


Hynda K. Kleinman, Ph.D. - Scientific Affairs

Experienced research scientist, executive and industry adviser. Former Chief, Cell Biology Section, CDBRB, NIDCR, NIH 


Jonathan Sleeman, Ph.D. - Cancer Recurrence Biology & Drug Discovery

Franz-Volhard Professor for Microvascular Biology and Pathobiology at the Medical Faculty Mannheim, University of Heidelberg  


Lawrence N. Kwong, Ph.D. - Cancer Recurrence Biology & Drug Discovery

Assistant Professor of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center


Mike Ihnat, Ph.D. - Cancer Recurrence Drug Discovery  
Associate Professor of Pharmacology, Department of Pharmaceutical Sciences, University of Oklahoma College of Pharmacy, Adjunct Associate Professor of Physiology, University of Oklahoma College of Medicine, Associate Member, Peggy and Charles Stephenson, Oklahoma Cancer Center, Experimental Therapeutics Program, University of Oklahoma College of Medicine, USA     

  

Pui-Kai (Tom) Li, Ph.D. - Drug Discovery 

Associate Professor, Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Ohio State University


Rafael Torgovicky, MD - Product Innovation, Business Development and Strategy
Experienced biopharma executive. Currently at Fortress Biotech. Formally Novartis, Merck & Co, and Vice President, External Innovation – Oncology at Eli Lilly and Company  


T.J. Sharpe – Patient Advocacy
Stage IV melanoma survivor, writer, advocate, and patient expert who began sharing his journey through cancer in the Patient #1 Blog on http://www.philly.com/patient1/


Xiaolin Cheng, Ph.D. - Drug Discovery 

Associate Professor,  Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Ohio State University